Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
April 12, 2001

Integrity Pharmaceutical Corp. Recalls Isoxsuprine HCI Tablets

Fishers, IN (SafetyAlerts) - The Food and Drug Administration (FDA) said today that Integrity Pharmaceutical Corp. has recalled certain Isoxsuprine HCI tablets because of metal particles in tablets.

This is the first public notice of this Class II recall issued by FDA.

PRODUCT
(Rx) Isoxsuprine HCI tablets, 20 mg, 1,000 count.

Recall #D-162-1.

CODES:
Lot Nos. 00504, 00602, and 00603.

MANUFACTURER:
Integrity Pharmaceutical Corp., Fishers, Indiana.

RECALLED BY:
Manufacturer, by telephone on August 14, 2000, and by letter on August 21, 2000. Firm-initiated recall ongoing.

DISTRIBUTION:
United States.

QUANTITY:
11,818 bottles.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

Notice of this product warning was sent via email to SafetyAlerts subscribers April 12, 2001.  For more information regarding the SafetyAlerts free email alert service please click here.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.